Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > Browse Articles > Previous issues
18 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 19(4); October 2026
Prev issue Next issue
Review Articles
Article image
Targeting the Gut to Modify Parkinson’s Disease: From Mechanisms to Potential Therapeutics
Yi-Cheng Tai, Chin-Hsien Lin
J Mov Disord. 2026;19(4):365-383.   Published online October 12, 2026
DOI: https://doi.org/10.14802/jmd.26285
  • 541 View
  • 51 Download
AbstractAbstract PDF
Parkinson’s disease (PD) is the second most common neurodegenerative disorder and its prevalence continues to rise with population aging. Its cardinal motor features arise from the loss of dopaminergic neurons in the substantia nigra, accompanied by intraneuronal α-synuclein aggregates known as Lewy bodies. Neuropathological evidence suggests that, in a subset of patients, α-synuclein pathology first appears in the enteric nervous system and ascends to the brain via the gut–brain axis. Consistent with this “body-first” trajectory, a growing body of work has documented distinct alterations in gut microbial composition and microbiota-derived metabolites in people with PD relative to healthy individuals, with some changes detectable in the prodromal phase. Current management, whether dopaminergic pharmacotherapy or deep brain stimulation, alleviates motor symptoms but does not slow neurodegeneration, and long-term treatment is complicated by motor fluctuations and other adverse effects. Therapies directed at the underlying disease process are therefore urgently needed. Because early perturbations of the gut microenvironment appear to contribute to PD pathogenesis, interventions that restore gut homeostasis represent a rational disease-modifying strategy, particularly for patients whose pathology originates in the gut. This review synthesizes current understanding of how the gut microbiota shapes the gut–brain axis in PD, spanning immune, metabolic, neuroendocrine, and neural pathways, and critically appraises the emerging evidence for microbiota-directed interventions, including fecal microbiota transplantation, probiotics, and prebiotics, as candidate disease-modifying therapies.
Article image
Candidate Neurobiological Pathways Linking Physical Exercise to Cognition in Parkinson’s Disease: A Hypothesis-Generating Translational Framework
Kyeongho Byun, Jee-Young Lee, Ryul Kim
J Mov Disord. 2026;19(4):384-397.   Published online October 12, 2026
DOI: https://doi.org/10.14802/jmd.26260
  • 551 View
  • 40 Download
AbstractAbstract PDF
Cognitive impairment is a major nonmotor symptom of Parkinson’s disease (PD), yet effective strategies for preserving cognitive function remain limited. Although physical exercise may confer cognitive benefits, the biological pathways linking exercise to cognition in PD remain incompletely established. This narrative review presents a hypothesis-generating translational framework for 4 candidate mechanistic domains that may contribute to exercise-related cognitive effects in PD. First, exercise-responsive neurotrophic signaling, particularly through brain-derived neurotrophic factor–tropomyosin receptor kinase B, insulin-like growth factor 1, and vascular endothelial growth factor pathways, may support synaptic plasticity, neuronal survival, and neurovascular function. Second, exercise may modulate dopaminergic, cholinergic, and noradrenergic systems and influence corticostriatal plasticity relevant to cognitive function. Third, muscle-derived factors and exercise-induced metabolites may affect neurotrophic signaling, neuronal metabolism, and autophagy–lysosomal clearance of α-synuclein. Fourth, exercise may regulate systemic and central inflammatory responses through cytokine signaling, glial activation, inflammasome pathways, and complement-mediated synaptic remodeling. The evidence supporting these pathways is derived from basic, preclinical, observational, and exercise-intervention studies, but the strength of evidence varies considerably across stages of translation. Direct evidence that exercise-induced biological changes mediate cognitive improvement in patients with PD is lacking. These pathways should therefore be regarded as candidate mechanisms for hypothesis-driven investigation of the cognitive effects of exercise in PD.
Original Articles
Article image
Disease Course, Survival, and Genetic Heterogeneity in Chorea-Acanthocytosis: A Case Series of 34 Patients
Aida Ghasemi, Elahe Amini, Ahmad Chitsaz, Gholamali Shahidi, Seyed Amir Hassan Habibi, Atieh Jafarabadi Ashtiani, Arezoo Farzi, Vadieh Ghodsinezhad, Afagh Alavi, Mohammad Rohani
J Mov Disord. 2026;19(4):398-408.   Published online July 14, 2026
DOI: https://doi.org/10.14802/jmd.25350
  • 958 View
  • 99 Download
AbstractAbstract PDFSupplementary Material
Objective
To quantify key disease milestones, particularly loss of ambulation and survival, and to describe the VPS13A variant spectrum and clinical heterogeneity in patients with chorea-acanthocytosis (ChA).
Methods
We conducted a cross-sectional study of 34 ChA patients from 24 unrelated families. Whole-exome sequencing identified VPS13A variants in all probands. Clinical and paraclinical data were collected through neurological evaluations and electronic medical records. Patients were classified as either surviving (ambulatory or non-ambulatory) or deceased.
Results
Twenty-one VPS13A variants were identified, including 12 novel variants. Median current age and disease duration were 38.5 years (interquartile range [IQR], 34–43 years) and 8.0 years (IQR, 4–12.25 years), respectively. Loss of ambulation occurred in 26.5% of patients after a median of 10 years (range, 5–16 years) from onset. Kaplan–Meier analysis estimated a median time to loss of ambulation of 16.0 years (95% confidence interval [CI], 8.8–23.2 years), with estimated ambulation probabilities of 87.4% at 6 years and 38.0% at 16 years. Seven patients died after a median disease duration of 10 years (range, 3–17 years). The median survival time was not reached during follow-up; the estimated restricted mean survival time was 16.7 years (95% CI, 14.1–19.3 years). Compulsions co-occurred with obsessions in all cases and were associated with higher rates of suicidal ideation, while insomnia was more frequent in patients without compulsions. Suicide and sepsis were the leading causes of death.
Conclusion
This study defines the natural history of ChA, providing prognostic data on ambulation and survival. The discovery of novel VPS13A variants highlights genetic heterogeneity and supports further investigation into disease mechanisms and therapeutic targets.
Article image
Distinct Patterns of Perivascular Diffusivity and Choroid Plexus Volume in De Novo Parkinson’s Disease and Type 2 Diabetes
Yun Jung Bae, Chaewon Shin, Hyunjae Jeong, Se Jin Cho, Sung Hyun Baik, So Yeong Jeong, Da Hyun Lee, Younbeom Jeong, Jong-Min Kim
J Mov Disord. 2026;19(4):409-418.   Published online August 18, 2026
DOI: https://doi.org/10.14802/jmd.26131
  • 636 View
  • 29 Download
AbstractAbstract PDF
Objective
Alterations in perivascular fluid dynamics have been implicated in Parkinson’s disease (PD) and metabolic disorders such as type 2 diabetes mellitus (T2DM). However, the relative contributions of neurodegenerative and metabolic conditions to functional perivascular water diffusivity versus structural neurofluid markers remain to be elucidated. To investigate the differences in perivascular water diffusivity and structural neurofluid markers using diffusion tensor image-analysis along the perivascular space (DTI-ALPS), perivascular space (PVS) burden, and choroid plexus volume (CPV) in PD and T2DM.
Methods
Consecutive patients with de novo PD and disease controls were included. Subjects were classified into four groups according to PD and T2DM status and matched for age and sex. The analysis along the perivascular space (ALPS)-index was derived from DTI, whereas PVS burden and CPV were quantified on three-dimensional T1-weighted images and normalized to intracranial volume.
Results
A total of 127 subjects were included. The ALPS-index differed significantly among the four groups (p<0.001), with both PD groups demonstrating significantly lower values than control groups, irrespective of T2DM status. Within the PD cohort, longer disease duration and older age were independently associated with lower ALPS-index values. CPV_ratio also differed significantly across groups (p=0.006) with higher values observed only in controls with T2DM, while PVS burden did not differ significantly.
Conclusion
In early-stage PD, impaired perivascular diffusivity was associated primarily with neurodegeneration, and no significant additive effect of T2DM was detected. Conversely, the increase in normalized CPV associated with T2DM was observed only in controls and not in PD, suggesting that metabolic and neurodegenerative conditions may differentially influence neurofluid markers.
Article image
Preliminary Reference Values for Dual-Task Gait Performance and Data-Driven Gait Profiles Across the Lifespan in Healthy Korean Adults
Bora Jin, Seungho Lee, Sang-Myung Cheon
J Mov Disord. 2026;19(4):419-430.   Published online August 18, 2026
DOI: https://doi.org/10.14802/jmd.26105
  • 602 View
  • 26 Download
AbstractAbstract PDF
Objective
Understanding normal gait characteristics is fundamental for characterizing disease-specific gait alterations. This study aimed to evaluate age-related differences in gait across various task conditions and identify data-driven gait profiles based on dual-task vulnerability in healthy Korean adults.
Methods
A cross-sectional gait assessment was conducted using GAITRite® under four conditions: preferred speed, serial sevens subtraction, cell phone use, and backward walking. Gait parameters were categorized into five domains: pace, variability, rhythm, asymmetry, and postural control. Participants were stratified into younger (<60 years) and older adults (≥60 years). Latent profile analysis (LPA) was performed using the dual-task cost variables to identify data-driven gait profiles.
Results
A total of 98 healthy adults aged 23–87 years were analyzed. Age-related differences were most pronounced during cell phone use, which was supported by significant age×task interaction effects across the pace, variability, rhythm, and postural control domains (pFDR<0.05). LPA identified three profiles: Pace-Preserved (Pa-P), Asymmetry-Dominant (Asym-D), and Postural control-Dominant (Pc-D). Younger adults were evenly distributed across the profiles, whereas older adults were predominantly classified into the Asym-D and Pc-D profiles. The Asym-D profile, characterized by the highest mean age, exhibited numerically lower cognitive scores, particularly in the visuospatial domain.
Conclusion
Regardless of chronological age groups and data-driven profiles, dual-task gait interference was most pronounced in the cognitive-motor dual-task condition. Data-driven profiling also identified a subgroup characterized by gait asymmetry, older age, and lower cognitive scores, suggesting a potentially distinct cognitive-motor pattern that warrants longitudinal investigation. These preliminary reference values provide a valuable foundation for the identification of pathological gait patterns in clinical populations.
Article image
Quantitative Analysis of Automatically Segmented Perivascular Space in Subcortical White Matter of Parkinson’s Disease: Its Clinical Relevance
Chae Jung Park, Yoonho Nam, Hyun-Jae Jeong, Han Kyu Na, Kyunghwa Han, Hye Sun Lee, Jun Hwee Kim, Seung-Koo Lee, Phil Hyu Lee, Yun Joong Kim, Young H. Sohn, Seok Jong Chung
J Mov Disord. 2026;19(4):431-441.   Published online August 28, 2026
DOI: https://doi.org/10.14802/jmd.26157
  • 629 View
  • 38 Download
AbstractAbstract PDF
Objective
To examine the relationship between automatically quantified perivascular space (PVS) extent located in the subcortical white matter (WM), baseline motor deficits and cognitive function, as well as longitudinal motor and cognitive outcomes in patients with Parkinson’s disease (PD).
Methods
This retrospective cohort study included 270 consecutive patients with newly diagnosed PD. Subcortical WM PVS was automatically segmented using high-resolution T2-weighted images, and automated PVS (aPVS) volume and count were calculated. Multivariate linear regression analyses evaluated the association between subcortical WM aPVS and baseline Unified Parkinson’s Disease Rating Scale Part III, Mini-Mental State Examination, and Montreal Cognitive Assessment scores. Cox regression models assessed the prognostic value of baseline subcortical WM aPVS for the risk of developing freezing of gait (FOG) and dementia.
Results
Greater subcortical WM aPVS volume, particularly in the frontal and parietal regions, correlated with milder parkinsonian motor deficits and better global cognitive function at baseline. Higher subcortical WM aPVS volume, especially in the frontal region, was linked to a lower risk of FOG (hazard ratio [HR], 0.53; 95% confidence interval [CI] 0.22–0.93; p=0.028). Additionally, greater subcortical WM aPVS volume, especially in the occipital region, was associated with a reduced risk of dementia conversion (HR, 0.38; 95% CI 0.10–0.95; p=0.041) in Cox regression models. Higher subcortical WM aPVS count was linked to better baseline motor symptoms, cognitive function, and lower risk of FOG.
Conclusion
These findings indicate that larger subcortical WM aPVS volume or higher aPVS count can be an indicator of favorable clinical outcomes in PD.
Article image
Quantitative Assessment of Facial Expression Asymmetry in Parkinson’s Disease
Atefeh Irani, Kye Won Park, Farnaz Sedaghati, Michael Grundy, Maryam S. Mirian, Reshad Hosseini, Hadi Moradi, Martin J. McKeown
J Mov Disord. 2026;19(4):442-452.   Published online September 22, 2026
DOI: https://doi.org/10.14802/jmd.26080
  • 555 View
  • 30 Download
AbstractAbstract PDF
Objective
Hypomimia, or reduced facial expressiveness, is a cardinal motor feature of Parkinson’s disease (PD). Although limb motor symptoms in PD are characteristically asymmetric, whether facial hypomimia exhibits comparable asymmetry remains poorly understood. We investigated facial expression asymmetry in PD using AI-based computer vision and machine learning.
Methods
Videos of instructed emotional facial expressions were collected from 101 individuals with PD and 94 healthy controls (HCs) across two independent cohorts. Facial landmarks were extracted to compute region-specific facial asymmetry indices. Static and dynamic features derived from these indices were compared between groups and used to train machine learning models for PD-HC discrimination, with each model trained and evaluated separately within each cohort. Facial mobility was additionally quantified for each hemiface as the summed velocity of landmark displacement to assess concordance with limb motor laterality.
Results
Individuals with PD exhibited greater facial asymmetry than HCs, most prominently in the eyebrow and periocular regions during happy expressions (p=0.01). Among participants with asymmetric limb parkinsonism, facial mobility was significantly reduced on the hemiface corresponding to the more affected limb (p=0.002), indicating concordant facial-limb lateralization. Machine learning models trained on dynamic facial asymmetry features achieved up to 90.1% cross-validated accuracy in distinguishing PD from HCs. The models had comparable within-cohort performance on held-out test sets.
Conclusion
Facial expression asymmetry is a measurable and lateralized feature of PD. Dynamic video-based analysis of facial asymmetry may offer an objective, scalable tool for assessing and monitoring facial motor function in PD.
Brief communications
Problematic Smartphone Use in Parkinson’s Disease: Associations With Mood, Non-Motor Burden, and Impulsivity
Müge Kuşoğlu, Mücahid Erdoğan, Banu Özen Barut
J Mov Disord. 2026;19(4):453-457.   Published online August 28, 2026
DOI: https://doi.org/10.14802/jmd.26203
  • 681 View
  • 50 Download
AbstractAbstract PDF
Objective
To investigate problematic smartphone use and its associations with mood symptoms, impulsivity, and non-motor symptom burden in Parkinson’s disease (PD).
Methods
A total of 45 patients with PD younger than 60 years and 43 matched healthy controls completed the Smartphone Addiction Scale (SAS), Beck Depression Inventory, and Beck Anxiety Inventory. Patients with PD additionally completed the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease–Rating Scale. Clinical characteristics and Movement Disorder Society–Unified Parkinson’s Disease Rating Scale scores were assessed.
Results
SAS scores were lower in PD than in controls. In PD, smartphone use was associated with depressive symptoms, anxiety, non-motor symptom burden, and impulsivity, although none remained independently associated in multivariable analysis. Positive anticipation showed the strongest association with impulsivity. In controls, depressive symptoms were associated only with the overuse and cyberspace-oriented relationships subscales.
Conclusion
Problematic smartphone use in PD appears to involve multiple behavioral dimensions, with overall use related to mood symptoms and reward-related use more closely linked to impulsivity.
Home-Based Visual Perceptual Learning Improves Contrast Sensitivity in Parkinson’s Disease: A Proof-of-Concept Study
Alba Herrero-Gracia, Rosa Hernández-Andrés, Santiago Martín-González, M. Amparo Díez-Ajenjo
J Mov Disord. 2026;19(4):458-462.   Published online October 6, 2026
DOI: https://doi.org/10.14802/jmd.26140
  • 422 View
  • 30 Download
AbstractAbstract PDF
Objective
To assess whether visual perceptual learning (VPL) enhances contrast sensitivity function (CSF) in Parkinson’s disease (PD); as a secondary exploratory aim, to describe whether the two protocols targeting different spatial frequency ranges produced differential effects.
Methods
A total of 17 patients with PD were randomized to two VPL protocols using dichoptic Gabor-patch video-games for 30 minutes/day, 6 days/week, over 8 weeks. The medium-high group trained at 8–16 cycles per degree (cpd) and the low-medium group at 0.5–2 cpd. CSF was measured at baseline, 2, 4, and 8 weeks. Best-corrected visual acuity and Visual Impairment in Parkinson’s Disease Questionnaire (VIPD-Q) were assessed at baseline and 8 weeks.
Results
Significant progressive improvements in CSF were observed across all spatial frequencies and in the area under the log CSF curve from 1 month of training (p<0.001). VIPD-Q scores improved significantly in both groups (p=0.017 and p=0.008, respectively).
Conclusion
Home-based VPL was associated with significant improvements in CSF in PD; however, the absence of a control group means that these findings remain preliminary.
Letters to the editor
Myotonic Dystrophy Type 1 With Normal-Pressure Hydrocephalus-Like Neuroimaging and a Negative Tap Test: Diagnostic Pitfalls and Management Considerations
Deep Faldu, Naresh Babu, Vikram V. Holla, Shweta Prasad, Meera Purushottam, Nitish Kamble, Ravi Yadav, Pramod Kumar Pal
J Mov Disord. 2026;19(4):463-466.   Published online April 27, 2026
DOI: https://doi.org/10.14802/jmd.26029
  • 1,328 View
  • 193 Download
PDFSupplementary Material
Painful Dystonia After Globus Pallidus Internus-Deep Brain Stimulation for Post-Stroke Hemiballism in an Older Patient
Daecheol Moon, Dallah Yoo, Chang Kyu Park, Tae-Beom Ahn
J Mov Disord. 2026;19(4):467-469.   Published online July 14, 2026
DOI: https://doi.org/10.14802/jmd.26103
  • 752 View
  • 98 Download
PDFSupplementary Material
Marked Improvement After Globus Pallidus Deep Brain Stimulation in Dystonia-24 With a Novel ANO3 Variant: A Case Report and Literature Review
Masataka Yamashiro, Tomoyo Hashimoto, Ryosuke Miyamoto, Yasushi Miyagi, Konoka Tachibana, Yuishin Izumi, Kazumasa Okada
J Mov Disord. 2026;19(4):470-472.   Published online July 24, 2026
DOI: https://doi.org/10.14802/jmd.26139
  • 1,142 View
  • 78 Download
PDFSupplementary Material
Progressive Ataxia With Palatal Tremor in a Patient Carrying the Prion Protein Gene M232R Variation: A Case Report
Hak-Loh Lee, Yeeun Sun, Han Kyu Na, Seok Jong Chung, Phil Hyu Lee
J Mov Disord. 2026;19(4):473-475.   Published online July 24, 2026
DOI: https://doi.org/10.14802/jmd.26153
  • 926 View
  • 34 Download
PDF
Early Improvement in Depressive Symptoms After Pallidothalamic Tract Deep Brain Stimulation for Drug-Induced Dystonia
Esraa Shaban, Joseph Turner, Clemens Neudorfer, Kilsoo Kim, Yoshihiro Noda, Shiro Horisawa
J Mov Disord. 2026;19(4):476-478.   Published online August 18, 2026
DOI: https://doi.org/10.14802/jmd.26125
  • 550 View
  • 33 Download
PDF
Eyelid Myoclonus in Subacute Sclerosing Panencephalitis–A Newly Recognised Slow Myoclonic Pattern?
Arunmozhimaran Elavarasi, Animesh Das, Ajay Garg, Anil Dash, Manjari Tripathi, Deepti Vibha, Rajesh Kumar Singh, Jasmine Parihar
J Mov Disord. 2026;19(4):479-482.   Published online September 2, 2026
DOI: https://doi.org/10.14802/jmd.26174
  • 377 View
  • 10 Download
PDF
Progressive Supranuclear Palsy With Coexisting Chronic Traumatic Encephalopathy and Multiple Tauopathies in a Non-Athlete With Recurrent Falls
Dallah Yoo, Seong-Ik Kim, Sung-Hye Park, Jae-Kyung Won, Tae-Beom Ahn
J Mov Disord. 2026;19(4):483-486.   Published online September 20, 2026
DOI: https://doi.org/10.14802/jmd.25252
  • 338 View
  • 12 Download
PDF
Expanding the Clinical Spectrum of ARSACS: An Atypical Adolescent-Onset Presentation With Compound Heterozygous SACS Variants
Jun Ho Heo, Min Jeong Han, Yun Su Hwang
J Mov Disord. 2026;19(4):487-490.   Published online October 12, 2026
DOI: https://doi.org/10.14802/jmd.26207
  • 269 View
  • 13 Download
PDF
Teaching Video
Levodopa-Induced Slow Dystonic Dyskinesia in a Patient With Progressive Supranuclear Palsy-Corticobasal Syndrome
Deepika Dalal, Jacky Ganguly, Debayan Dutta, Shreyashi Jha, Japleen Kaur, Shib Shankar Bhattacharyya, Hrishikesh Kumar
J Mov Disord. 2026;19(4):491-492.   Published online October 29, 2026
DOI: https://doi.org/10.14802/jmd.26258
  • 321 View
  • 15 Download
PDF

JMD : Journal of Movement Disorders bluesky InBug Facebook X
Close layer
TOP